Bookmark
Forward
QuickView for Cephaloglycin (compound)
PubChem
| Name: | Cephaloglycin |
|---|---|
| PubChem Compound ID: | 166592 |
| Description: | A cephalorsporin antibiotic. |
| Molecular formula: | C18H23N3O8S |
| Molecular weight: | 441.457 g/mol |
| Synonyms: |
Cephaloglycin [USAN:USP XX:BAN]; Kefocin (TN); CEG; D03439; 22202-75-1; 5-Thia-1-azabicyclo; Cephaloglycin (USAN); Kefocin; Cephaloglycin
|
DrugBank
Identification
| Name: | Cephaloglycin |
|---|---|
| Name (isomeric): | DB00689 |
| Drug Type: | small molecule |
| Description: | A cephalorsporin antibiotic. |
| Brand: | Cefaloglicina [INN-Spanish], Kefglycin, Kafocin, Cephaloglycin anhydrous, D-Cephaloglycine, Cephaoglycin acid, Cefaloglycinum [INN-Latin], CEG, Cefaloglycin, Cephaloglycine, Cefaloglycine [INN-French] |
| Category: | Cephalosporins, Anti-Bacterial Agents |
| CAS number: | 3577-01-3 |
Pharmacology
| Indication: | For treatment of severe infections caused by susceptible bacteria. |
|---|---|
| Pharmacology: | Cephaloglycin is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C. |
| Mechanism of Action: | The bactericidal activity of cephaloglycin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). |
| Absorption: | Well absorbed following oral administration. |
| Toxicity: | Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions. |
| Affected organisms: | Enteric bacteria and other eubacteria |
Interactions
| Drug interaction: |
|
|---|
Targets
Transporters
